In vitro studies of the effects of β-adrenergic drugs on retinal and posterior ciliary microarteries

Survey of Ophthalmology

Volumn 43, Issue 6 SUPPL., 1999, Pages

  Hoste, Ann M ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

blockers; Blood flow; Ca2+channel blockers; Glaucoma; Hypertension; Microcirculation; Pharmacology; Smooth muscle

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETAXOLOL; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; ISOPRENALINE; PROPRANOLOL; TERTATOLOL;

ANIMAL TISSUE; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD VESSEL INJURY; CILIARY ARTERY; CONFERENCE PAPER; DRUG EFFECT; DRUG RECEPTOR BINDING; MICROCIRCULATION; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; RETINA ARTERY; RETINA BLOOD FLOW; STEREOSPECIFICITY; VASCULAR ENDOTHELIUM; VASODILATATION;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CILIARY ARTERIES; MICROCIRCULATION; MUSCLE, SMOOTH, VASCULAR; MYOGRAPHY; OPTIC DISK; REPRODUCIBILITY OF RESULTS; RETINAL ARTERY; VASOCONSTRICTION; VASODILATION;

EID: 0032776456     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6257(99)00045-4     Document Type: Conference Paper

References (66)

1. Adam G., Schwartz B. Increased fluorescein filling defects in the wall of the optic disc cup in glaucoma. Arch Ophthalmol. 98:1980;1590-1592.
2. Alm A. Effects of norepinephrine, angiotensin, dihydroergotamine, papaverine, isoproterenol, histamine, nicotinic acid, and xanthinol nicotinate on retinal oxygen tension in cats. Acta Ophthalmol. 50:1972;707-719.
3. Barrett A.M., Cullum V.A. The biological properties of the optical isomers of propranolol and their effects on cardiac arrhytmias. Br J Pharmacol. 34:1968;43-55.
4. Bessho H., Suzuki J., Tobe A. Vascular effects of betaxolol, a cardioselective beta-adrenoceptor antagonist, in isolated rat arteries. Jpn J Pharmacol. 55:1991;351-358.
5. Bevan J.A., Bevan R.D., Hwa J.J.et al. Calcium regulation in vascular smooth muscle. is there a pattern to its variability within the arterial tree? J Cardiovasc Pharmacol. 8(Suppl):1986;S71-S75.
6. Bevan J.A., Osher J.V. A direct method for recording tension changes in the wall of small blood vessels in vitro. Agents Actions. 2:1972;257-260.
7. Boonen H.C., Struyker-Boudier H.A., De Mey J.G. Effects of tertatolol on the responsiveness of isolated femoral, mesenteric, and renal resistance arteries to adrenergic stimuli. J Cardiovasc Pharmacol. 15:1990;124-129.
8. Butryn R.K., Ruan H., Hull C.M., Frank R.N. Vasoactive agonists do not change the caliber of retinal capillaries of the rat. Microvasc Res. 50:1995;80-93.
9. Cauvin C., Lukeman S., Cameron J.et al. Differences in norepinephrine activation and diltiazem inhibition of calcium channels in isolated rabbit aorta and mesenteric resistance vessels. Circ Res. 56:1985;822-828.
10. 2+ dependence and diltiazem inhibition of contraction in rabbit conduit arteries and mesenteric resistance vessels. Blood Vessels. 21:1984;23-31.
11. Chiou G.C., Chen Y.J. Effects of D- and L-isomers of timolol on retinal and choroidal blood flow in ocular hypertensive rabbit eyes. J Ocul Pharmacol. 8:1992;183-190.
12. Desantis L., Dahlin D., Barnes G. A role for the calcium channel blocking-like action of betaxolol for providing therapeutic benefit to glaucoma patients. Drance S.M. Update to Glaucoma, Ocular Blood Flow and Drug Treatment. 1995;137-143 Kugler Publications, Amsterdam.
13. Duling B.R., Gore R.W., Dacey R.G. Jr., Damon D.N. Methods for isolation, cannulation, and in vitro study of single microvessels. Am J Physiol. 241:1981;H108-H116.
14. Dunn W.R., Wellman G.C., Bevan J.A. Enhanced resistance artery sensitivity to agonists under isobaric compared with isometric conditions. Am J Physiol. 266:1994;H147-H155.
15. Ferrari-Dileo G. Beta 1 and beta 2 adrenergic binding sites in bovine retina and retinal blood vessels. Invest Ophthalmol Vis Sci. 29:1988;695-699.
16. Ferrari-Dileo G., Davis E.B., Anderson D.R. Effects of cholinergic and adrenergic agonists on adenylate cyclase activity of retinal microvascular pericytes in culture. Invest Ophthalmol Vis Sci. 33:1992;42-47.
17. Gaspar A.Z., Flammer J., Hendrickson P. Influence of nifedipine on the visual fields of patients with optic-nerve-head diseases. Eur J Ophthalmol. 4:1994;24-28.
18. Gasser P., Flammer J. Blood-cell velocity in the nailfold capillaries of patients with normal-tension and high-tension glaucoma. Am J Ophthalmol. 111:1991;585-588.
19. Geijssen H.C., Greve E.L. Vascular concepts in glaucoma. Curr Opin Ophthalmol. 6:1995;71-77.
20. Graham S.L., Drance S.M., Wijsman K.et al. Ambulatory blood pressure monitoring in glaucoma. The nocturnal dip Ophthalmology. 102:1995;61-69.
21. Grunwald J.E. Retinal hemodynamics in open-angle glaucoma. Lambrou G.N., Greve E.L. Ocular Blood Flow in Glaucoma. 1989;147-149 Kugler & Ghedini Publications, Amsterdam.
22. Grunwald J.E. Effect of topical timolol on the human retinal circulation. Invest Ophthalmol Vis Sci. 27:1986;1713-1719.
23. Harris A., Spaeth G.L., Sergott R.C.et al. Retrobulbar arterial hemodynamic effects of betaxolol and timolol in normal-tension glaucoma. Am J Ophthalmol. 120:1995;168-175.
24. Hattori Y., Nakaya H., Endou M.et al. Vascular effects of carvedilol, a new beta-adrenoceptor antagonist with vasodilating properties, in isolated canine coronary artery. J Cardiovasc Pharmacol. 13:1989;572-579.
25. Hayreh S.S. Blood supply to the optic nerve in health and disease. Lambrou G.N., Greve E.L. Ocular Blood Flow in Glaucoma. 1989;3-48 Kugler & Ghedini Publications, Amsterdam.
26. Hayreh S.S., Revie I.H., Edwards J. Vasogenic origin of visual field defects and optic nerve changes in glaucoma. Br J Ophthalmol. 54:1970;461-472.
27. Hayreh S.S., Zimmerman M.B., Podhajsky P., Alward W.L. Nocturnal arterial hypotension and its role in optic nerve heard and ocular ischemic disorders. Am J Ophthalmol. 117:1994;603-624.
28. Hester R.K., Chen Z., Becker E.J.et al. The direct vascular relaxing action of betaxolol, carteolol and timolol in porcine long posterior ciliary artery. Surv Ophthalmol. 38(Suppl):1994;S125-S134.
29. Hoste A.M., Boels P.J., Andries L.J.et al. Effects of beta-antagonists on contraction of bovine retinal microarteries in vitro. Invest Ophthalmol Vis Sci. 31:1990;1231-1237.
30. Hoste A.M., Boels P.J., Brutsaert D.L., De Laey J.J. Effects of alpha-1 and beta agonists on contraction of bovine retinal resistance arteries in vitro. Invest Ophthalmol Vis Sci. 30:1989;44-50.
31. Hoste A.M., Sys S.U. Ca2+ channel-blocking activity of propranolol and betaxolol in isolated bovine retinal microartery. J Cardiovasc Pharmacol. 32:1998;390-396.
32. Hoste A.M., Sys S.U. The relaxant action of betaxolol on isolated bovine retinal microarteries. Curr Eye Res. 13:1994;483-487.
33. Howe R., Shanks R.G. Optical isomers of propranolol. Nature. 210:1966;1336-1338.
34. Jay W.M., Aziz M.Z., Green K. Effect of topical epinephrine and timolol on ocular and optic nerve blood flow in phakic and aphakic rabbit eyes. Curr Eye Res. 3:1984;1199-1202.
35. Kaiser H.J., Flammer J. Systemic hypotension. a risk factor for glaucomatous damage? Ophthalmologica. 203:1991;105-108.
36. Khuu H.D., Lam K.W., Sponsel W.E. Transconjunctival diffusion of timolol and betaxolol (abstract). Invest Ophthalmol Vis Sci. 37(Suppl):1996;S1101.
37. Kitazawa Y., Shirai H., Go F.J. The effect of Ca2(+) -antagonist on visual field in low-tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 227:1989;408-412.
38. Laties A.M. Central retinal artery innervation. Absence of adrenergic innervation to the intraocular branches. Arch Ophthalmol. 77:1967;405-409.
39. Malik A.B., van Heuven W.A., Satler L.F. Effects of isoproterenol and norepinephrine on regional ocular blood flows. Invest Ophthalmol Vis Sci. 15:1976;492-495.
40. Martin X.D., Rabineau P.A. Vasoconstrictive effect of topical timolol on human retinal arteries. Graefes Arch Clin Exp Ophthalmol. 227:1989;526-530.
41. Matthews J.C., Baker J.K. Effects of propranolol and a number of its analogues on sodium channels. Biochem Pharmacol. 31:1982;1681-1685.
42. Morgan T.R., Green K., Bowman K. Effects of adrenergic agonists upon regional ocular blood flow in normal and ganglionectomized rabbits. Exp Eye Res. 32:1981;691-697.
43. Mulvany M.J., Aalkjaer C. Structure and function of small arteries. Physiol Rev. 70:1990;921-961.
44. Mulvany M.J., Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 41:1977;19-26.
45. Mulvany M.J., Halpern W. Mechanical properties of vascular smooth muscle cells in situ. Nature. 260:1976;617-619.
46. Musini A., Fabbri B., Bergamaschi M.et al. Comparison of the effect of propranolol, lignocaine, and other drugs on normal and raised intraocular pressure in man. Am J Ophthalmol. 72:1971;773-781.
47. Netland P.A., Chaturvedi N., Dreyer E.B. Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am J Ophthalmol. 115:1993;608-613.
48. Nielsen P.J., Nyborg N.C. Adrenergic responses in isolated bovine retinal resistance arteries. Int Ophthalmol. 13:1989;103-107.
49. Nyborg N.C., Nielsen P.J. Beta-adrenergic receptors regulating vascular smooth muscle tone are only localized to the intraocular segment of the long posterior ciliary artery in bovine eye. Surv Ophthalmol. 39(Suppl):1995;S66-S75.
50. Orgul S., Mansberger S., Bacon D.R.et al. Optic nerve vasomotor effects of topical beta-adrenergic antagonists in rabbits. Am J Ophthalmol. 120:1995;441-447.
51. Phillips C.I., Howitt G., Rowlands D.J. Propranolol as ocular hypotensive agent. Br J Ophthalmol. 51:1967;222-226.
52. Pillunat L.E., Stodtmeister R., Wilmanns I. Pressure compliance of the optic nerve head in low tension glaucoma. Br J Ophthalmol. 71:1987;181-187.
53. Pillunat L.E., Stodtmeister R., Wilmanns I., Metzner D. Effect of timolol on optic nerve head autoregulation. Ophthalmologica. 193:1986;146-153.
54. Rokutanda M., Araki S., Sakanashi M. A pharmacological investigation on a possible calcium antagonistic action of propranolol. Arch Int Pharmacodyn Ther. 262:1983;99-108.
55. Sakanashi M., Takeo S. Characterization of propranolol-induced relaxation of coronary artery. Jpn J Pharmacol. 33:1983;603-610.
56. Schwartz B. Circulatory defects of the optic disk and retina in ocular hypertensin and high pressure open-angle glaucoma. Surv Ophthalmol. 38(Suppl):1994;S23-S34.
57. Setoguchi M., Ohya Y., Abe I., Fujishima M. Inhibitory actin of betaxolol, a beta 1-selective adrenoceptor antagonist, on voltage-dependent calcium channels in guinea-pig artery and vein. Br J Pharmacol. 115:1995;198-202.
58. Sponer G., Bartsch W., Strein K.et al. Pharmacological profile of carvedilol as a beta-blocking agent with vasodilating and hypotensive properties. J Cardiovasc Pharmacol. 9:1987;317-327.
59. Sponer G., Strein K., Bartsch W., Muller-Beckmann B. Vasodilatory actin of carvedilol. J Cardiovasc Pharmacol. 19(Suppl):1992;S5-S11.
60. Vuori M.L., Ali-Melkkila T., Kaila T.et al. Plasma and aqueous humour concentrations and systemic effects of topical betaxolol and timolol in man. Acta Ophthalmol. 71:1993;201-206.
61. Weinstock M. The presynaptic effect of beta-adrenoceptor antagonists on noradrenergic neurones. Life Sci. 19:1976;1453-1466.
62. Wise G.N., Dollery C.T., Henkind P. Physiologic principles, in. The Retinal Circulation:1971;Harper and Row, New York.
63. Yu D.Y., Su E.N., Alder V.A.et al. Pharmacological and mechanical heterogeneity of cat isolated ophthalmociliary artery. Exp Eye Res. 54:1992;347-359.
64. Yu D.Y., Su E.N., Cringle S.J.et al. Effect of betaxolol, timolol and nimodipine on human and pig retinal arterioles. Exp Eye Res. 67:1998;73-81.
65. Yu D.Y., Su E.N., Cringle S.J. Effects of beta blockers and Ca2+ entry blockers on ocular vessels. Drance S.M. Vascular Risk Factors and Neuroprotection in Glaucoma. 1997;123-134 Kugler Publications, Amsterdam.
66. Zschauer A.O., Davis E.B., Anderson D.R. Glaucoma, capillaries and pericytes. 4. Beta-adrenergic activation of cultured retinal pericytes Ophthalmologica. 210:1996;276-279.